ResMed releases new forward-thinking connected care solution for SDB treatment

ResMed (NYSE: RMD) today announced Air Solutions, a new forward-thinking connected care solution for treating sleep-disordered breathing that can benefit all stakeholders in the care continuum. The ResMed Air Solutions platform has data-driven components that span from diagnosis to treatment, compliance management and patient engagement.

ResMed, a pioneer in the treatment of sleep-disordered breathing (SDB), has been the industry's premier innovator, with award winning customer-centric products that have significantly improved patient acceptance and adherence to SDB therapy.

Ecosystem Approach Brings Increased Efficiency and Efficacy to SDB Treatment

"With Air Solutions, we're creating a new beginning in patient care," said Don Darkin, president of the ResMed Sleep-Disordered Breathing Business Unit. "As we unveil each Air Solutions component, our signature differentiation of superior performance and comfort will be underscored, made even stronger with groundbreaking technology that helps providers become more connected with their patients."

Air Solutions comprises components that, together, create a comprehensive end-to-end ecosystem that directly addresses the pain points for each stakeholder in the patient's therapy, including physicians, sleep labs, home medical equipment providers, and the patients themselves. The ecosystem approach, Darkin says, can increase efficiency and treatment efficacy by keeping providers informed and patients engaged. Included in the Air Solutions platform are:

ApneaLink™ Air: ResMed's compact and lightweight home sleep testing device works seamlessly with AirView software (see below) to empower sleep labs to efficiently manage each step of the diagnostic process, and share data to appropriate user groups.

AirSense™ 10 Series: ResMed's new series of continuous and automatic positive airway pressure devices (CPAP and APAP) called AirSense 10 that have advanced data and communications features to streamline the set-up, compliance management and compliance monitoring processes. This brand new device platform is also intuitive and easy-to-use, and offers a smaller bedside footprint.

AirCurve™ 10 Series: The AirCurve 10 series includes a range of bi-level devices that meet a variety of patient conditions and needs, such as patients who need extra pressure support, as well as an ASV device for patients with Cheyne-Stokes respiration or who require adaptive-servo-ventilation.

AirFit™ Masks: Announced earlier this year, the AirFit masks are known by their easy fit and superior comfort. The AirFit line includes the AirFit P10 nasal pillows system, which is the current market leader among new patients, the AirFit F10 full-face mask and the AirFit N10 nasal mask.

AirView™ Monitoring and Compliance Management System: When used in conjunction with Air Solutions devices, the AirView software solution significantly streamlines the patient management process by providing troubleshooting, fault detection and more. AirView enables data on demand, with patient data available in just one hour after a patient's therapy session has ended.

myAir Patient Engagement Application and Software: An engaged patient is more likely to be compliant, and myAir helps patients better understand their own sleep data, with data dashboards, coaching and reinforcement messages.

ApneaLink Air and AirFit masks are available now in the U.S. and other select markets. The AirSense 10 and AirView will be available in the U.S. and Australia on Aug. 18, and other markets later this calendar year. The AirCurve 10 Series and myAir will also be available later this calendar year.

Source:

ResMed Inc.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    ResMed Corp. (2019, June 19). ResMed releases new forward-thinking connected care solution for SDB treatment. News-Medical. Retrieved on December 11, 2024 from https://www.news-medical.net/news/20140811/ResMed-releases-new-forward-thinking-connected-care-solution-for-SDB-treatment.aspx.

  • MLA

    ResMed Corp. "ResMed releases new forward-thinking connected care solution for SDB treatment". News-Medical. 11 December 2024. <https://www.news-medical.net/news/20140811/ResMed-releases-new-forward-thinking-connected-care-solution-for-SDB-treatment.aspx>.

  • Chicago

    ResMed Corp. "ResMed releases new forward-thinking connected care solution for SDB treatment". News-Medical. https://www.news-medical.net/news/20140811/ResMed-releases-new-forward-thinking-connected-care-solution-for-SDB-treatment.aspx. (accessed December 11, 2024).

  • Harvard

    ResMed Corp. 2019. ResMed releases new forward-thinking connected care solution for SDB treatment. News-Medical, viewed 11 December 2024, https://www.news-medical.net/news/20140811/ResMed-releases-new-forward-thinking-connected-care-solution-for-SDB-treatment.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
ResMed and ATS Foundation award $100,000 to COPD digital health researcher